AYYAN loses SAR 164.4M in 2024, SAR 25.8M in Q4

06/03/2025 Argaam Exclusive

View other reports

AYYAN Investment Co. narrowed its losses to SAR 164.4 million in 2024, from SAR 216.3 million a year earlier.

Financials (M)

Item	2023	2024	Change‬
Revenues	20.09	15.44	(23.1 %)
Gross Income	3.66	2.45	(33.1 %)
Operating Income	(8.63)	(13.13)	(52.1 %)
Net Income	(216.25)	(164.41)	24.0 %
Average Shares	88.35	92.72	4.9 %
Earnings Per Share before unusual items	(2.45)	(1.77)	27.6 %
EPS (Riyals)	(2.45)	(1.77)	27.6 %

This came as losses from discontinued operations contracted, driven by lower losses at Al-Salam Medical Services Co., as Al-Salam Hospital’s revenue surged to SAR 196.5 million in 2024, from SAR 50.8 million in 2023. This was supported by higher patient volumes and improved operational efficiency.

This, along with lower cost of revenue, a decline in selling and marketing expenses, and a higher share of profits from an associate company, offset the impact of lower sales volumes in 2024.

Notably, all revenue and expenses of Al-Ahsa Medical Services Co. and Al-Salam Medical Services (both subsidiaries) have been classified under discontinued operations, with net results reported accordingly.

Comparative figures have also been restated to align with IFRS 5.

Q4 2024 net loss reached SAR 25.77 million, down from SAR 71.88 million in Q4 2023.

On a sequential basis, AYYAN’s net losses shrank from SAR 34.68 million in Q3 2024.

Current Quarter Comparison (M)

Compared With The

Item	Q4 2023	Q4 2024	Change‬
Revenues	5.01	3.16	(36.8 %)
Gross Income	0.76	0.88	16.4 %
Operating Income	(4.73)	(7.56)	(59.7 %)
Net Income	(71.88)	(25.77)	64.1 %
Average Shares	88.35	92.72	4.9 %
Earnings Per Share before unusual items	(0.81)	(0.28)	65.8 %
EPS (Riyals)	(0.81)	(0.28)	65.8 %

Item	Q3 2024	Q4 2024	Change‬
Revenues	3.25	3.16	(2.7 %)
Gross Income	0.34	0.88	161.2 %
Operating Income	(2.21)	(7.56)	(241.8 %)
Net Income	(34.68)	(25.77)	25.7 %
Average Shares	92.72	92.72	-
Earnings Per Share before unusual items	(0.37)	(0.28)	25.7 %
EPS (Riyals)	(0.37)	(0.28)	25.7 %

Total shareholders’ equity, after minority interest, stood at SAR 606.87 million by Dec. 31, 2024, compared to SAR 500 million a year earlier.

View More Financial Results

Profit Performance (Million)

Period	Net Income	Change	EPS(Riyal)	Extraordinary Income/Expense	Net Profit Before Unusual Items	Earnings Per Share before unusual items
Q1 2015	4.74	0.9 %	0.09	2.97	1.77	0.03
Q2 2015	29.26	811.3 %	0.54	2.84	26.42	0.49
Q3 2015	7.56	159.0 %	0.14	23.19	(15.62)	(0.29)
Q4 2015	(0.41)	98.2 %	(0.01)	-	(0.41)	(0.01)
2015	52.09	244.4 %	0.97	53.21	(1.13)	(0.02)
Q1 2016	(2.79)	(158.8 %)	(0.05)	(1.47)	(1.32)	(0.02)
Q2 2016	(12.83)	(143.8 %)	(0.24)	(1.75)	(11.08)	(0.21)
Q3 2016	(2.88)	(138.1 %)	(0.05)	-	(2.88)	(0.05)
Q4 2016	(14.17)	(3,382.6 %)	(0.26)	(13.12)	(1.05)	(0.02)
2016	(33.39)	(164.1 %)	(0.62)	(16.35)	(17.05)	(0.32)
Q1 2017	1.00	135.9 %	0.02	-	1.00	0.02
Q2 2017	1.59	112.4 %	0.03	-	1.59	0.03
Q3 2017	(2.11)	26.6 %	(0.04)	(2.50)	0.39	0.01
Q4 2017	(9.93)	30.0 %	(0.18)	-	(9.93)	(0.18)
2017	(9.45)	71.7 %	(0.18)	(2.50)	(6.95)	(0.13)
Q1 2018	(2.79)	(378.1 %)	(0.05)	-	(2.79)	(0.05)
Q2 2018	0.32	(79.6 %)	0.01	-	0.32	0.01
Q3 2018	1.17	155.4 %	0.02	-	1.17	0.02
Q4 2018	8.51	185.8 %	0.16	-	8.51	0.16
2018	7.22	176.4 %	0.13	-	7.22	0.13
Q1 2019	1.42	151.0 %	0.03	-	1.42	0.03
Q2 2019	1.98	510.8 %	0.04	-	1.98	0.04
Q3 2019	2.30	96.8 %	0.04	-	2.30	0.04
Q4 2019	(6.88)	(180.9 %)	(0.13)	-	(6.88)	(0.13)
2019	(1.28)	(117.8 %)	(0.02)	-	(1.28)	(0.02)
Q1 2020	15.91	1020.3 %	0.20	14.58	1.33	0.02
Q2 2020	3.96	100.0 %	0.05	-	3.96	0.05
Q3 2020	9.19	299.2 %	0.11	3.01	6.18	0.08
Q4 2020	(1.76)	74.4 %	(0.02)	-	(1.76)	(0.02)
2020	27.29	2225.7 %	0.34	17.59	9.70	0.12
Q1 2021	7.37	(53.7 %)	0.09	-	7.37	0.09
Q2 2021	0.62	(84.4 %)	0.01	-	0.62	0.01
Q3 2021	3.74	(59.4 %)	0.05	-	3.74	0.05
Q4 2021	(7.42)	(321.2 %)	(0.09)	-	(7.42)	(0.09)
2021	4.29	(84.3 %)	0.05	-	4.29	0.05
Q1 2022	13.42	82.1 %	0.15	-	13.42	0.15
Q2 2022	(11.73)	(2003.4 %)	(0.13)	-	(11.73)	(0.13)
Q3 2022	(16.75)	(548.4 %)	(0.19)	-	(16.75)	(0.19)
Q4 2022	(29.71)	(300.2 %)	(0.34)	-	(29.71)	(0.34)
2022	(44.77)	(1142.5 %)	(0.51)	-	(44.77)	(0.51)
Q1 2023	(46.65)	(447.7 %)	(0.53)	-	(46.65)	(0.53)
Q2 2023	(41.29)	(252.1 %)	(0.47)	-	(41.29)	(0.47)
Q3 2023	(56.43)	(236.9 %)	(0.64)	-	(56.43)	(0.64)
Q4 2023	(71.88)	(142.0 %)	(0.81)	-	(71.88)	(0.81)
2023	(216.25)	(383.1 %)	(2.45)	-	(216.25)	(2.45)
Q1 2024	(55.65)	(19.3 %)	(0.63)	-	(55.65)	(0.63)
Q2 2024	(48.30)	(17.0 %)	(0.55)	-	(48.30)	(0.55)
Q3 2024	(34.68)	38.5 %	(0.37)	-	(34.68)	(0.37)
Q4 2024	(25.77)	64.1 %	(0.28)	-	(25.77)	(0.28)
2024	(164.41)	24.0 %	(1.77)	-	(164.41)	(1.77)

Period	Net Income	Change	EPS(Riyal)	Extraordinary Income/Expense	Net Profit Before Unusual Items	Earnings Per Share before unusual items
2015	52.09	244.4 %	0.97	53.21	(1.13)	(0.02)
2016	(33.39)	(164.1 %)	(0.62)	(16.35)	(17.05)	(0.32)
2017	(9.45)	71.7 %	(0.18)	(2.50)	(6.95)	(0.13)
2018	7.22	176.4 %	0.13	-	7.22	0.13
2019	(1.28)	(117.8 %)	(0.02)	-	(1.28)	(0.02)
2020	27.29	2225.7 %	0.34	17.59	9.70	0.12
2021	4.29	(84.3 %)	0.05	-	4.29	0.05
2022	(44.77)	(1142.5 %)	(0.51)	-	(44.77)	(0.51)
2023	(216.25)	(383.1 %)	(2.45)	-	(216.25)	(2.45)
2024	(164.41)	24.0 %	(1.77)	-	(164.41)	(1.77)

Financial results (Million)

Period	Revenues	Change	Gross Income	Change	Operating Income	Change
Q1 2015	9.51	1202.9 %	2.66	132900.0 %	(0.85)	51.7 %
Q2 2015	47.51	1820.4 %	13.14	2176.6 %	(0.32)	66.4 %
Q3 2015	43.30	4157.4 %	10.82	13141.0 %	(1.72)	32.9 %
Q4 2015	50.24	1858.1 %	12.67	4989.2 %	(0.51)	92.2 %
2015	150.56	2118.7 %	38.41	5090.9 %	(4.28)	64.0 %
Q1 2016	49.61	421.6 %	12.71	378.4 %	(1.20)	(41.8 %)
Q2 2016	49.61	4.4 %	12.68	(3.4 %)	(1.11)	(243.3 %)
Q3 2016	45.23	4.5 %	13.43	24.1 %	(0.80)	53.8 %
Q4 2016	47.48	(5.5 %)	9.52	(24.9 %)	(4.28)	(733.7 %)
2016	191.93	27.5 %	48.30	25.7 %	(7.42)	(73.4 %)
Q1 2017	50.64	2.1 %	12.56	(1.2 %)	(1.94)	(61.3 %)
Q2 2017	55.45	11.8 %	15.06	18.8 %	0.61	154.7 %
Q3 2017	49.78	10.1 %	12.73	(5.2 %)	(1.10)	(38.4 %)
Q4 2017	53.20	12.0 %	12.54	31.8 %	(4.73)	(10.7 %)
2017	209.07	8.9 %	52.90	9.5 %	(7.17)	3.5 %
Q1 2018	53.02	4.7 %	12.41	(1.2 %)	(2.51)	(29.8 %)
Q2 2018	53.67	(3.2 %)	12.13	(19.5 %)	(0.77)	(227.0 %)
Q3 2018	57.55	15.6 %	14.21	11.6 %	(0.42)	61.9 %
Q4 2018	61.42	15.5 %	13.99	11.5 %	(2.18)	54.0 %
2018	225.65	7.9 %	52.73	(0.3 %)	(5.88)	17.9 %
Q1 2019	57.62	8.7 %	14.62	17.9 %	0.40	115.8 %
Q2 2019	58.62	9.2 %	14.98	23.5 %	(0.66)	14.8 %
Q3 2019	60.26	4.7 %	15.68	10.4 %	0.52	223.6 %
Q4 2019	69.00	12.3 %	24.10	72.3 %	(6.56)	(201.4 %)
2019	245.51	8.8 %	69.38	31.6 %	(6.30)	(7.2 %)
Q1 2020	63.33	9.9 %	16.01	9.5 %	0.16	(58.9 %)
Q2 2020	61.42	4.8 %	16.44	9.7 %	0.77	217.8 %
Q3 2020	65.95	9.4 %	18.98	21.0 %	2.11	306.0 %
Q4 2020	64.62	(6.3 %)	16.45	(31.8 %)	(1.32)	80.0 %
2020	255.32	4.0 %	67.87	(2.2 %)	1.73	127.4 %
Q1 2021	72.53	14.5 %	21.45	34.0 %	1.87	1045.3 %
Q2 2021	70.43	14.7 %	20.00	21.7 %	(2.79)	(459.9 %)
Q3 2021	65.80	(0.2 %)	16.61	(12.5 %)	2.08	(1.3 %)
Q4 2021	60.80	(5.9 %)	6.50	(60.5 %)	(11.29)	(758.5 %)
2021	269.56	5.6 %	64.55	(4.9 %)	(10.12)	(685.4 %)
Q1 2022	75.60	4.2 %	19.13	(10.8 %)	1.56	(16.5 %)
Q2 2022	65.86	(6.5 %)	12.96	(35.2 %)	(8.55)	(206.8 %)
Q3 2022	68.13	3.5 %	13.84	(16.6 %)	(19.85)	(1054.2 %)
Q4 2022	56.64	(6.8 %)	(29.09)	(547.8 %)	(30.30)	(168.4 %)
2022	266.23	(1.2 %)	16.83	(73.9 %)	(57.14)	(464.4 %)
Q1 2023	69.19	(8.5 %)	(11.90)	(162.2 %)	(40.22)	(2673.6 %)
Q2 2023	76.49	16.1 %	(2.42)	(118.7 %)	(37.16)	(334.8 %)
Q3 2023	4.31	(93.7 %)	0.12	(99.2 %)	(1.89)	90.5 %
Q4 2023	5.01	(91.2 %)	0.76	102.6 %	(4.73)	84.4 %
2023	20.09	(92.5 %)	3.66	(78.2 %)	(8.63)	84.9 %
Q1 2024	99.83	44.3 %	(13.64)	(14.6 %)	(44.20)	(9.9 %)
Q2 2024	3.86	(95.0 %)	0.44	118.1 %	(1.90)	94.9 %
Q3 2024	3.25	(24.7 %)	0.34	191.4 %	(2.21)	(16.7 %)
Q4 2024	3.16	(36.8 %)	0.88	16.4 %	(7.56)	(59.7 %)
2024	15.44	(23.1 %)	2.45	(33.1 %)	(13.13)	(52.1 %)

Period	Revenues	Change	Gross Income	Change	Operating Income	Change
2015	150.56	2118.7 %	38.41	5090.9 %	(4.28)	64.0 %
2016	191.93	27.5 %	48.30	25.7 %	(7.42)	(73.4 %)
2017	209.07	8.9 %	52.90	9.5 %	(7.17)	3.5 %
2018	225.65	7.9 %	52.73	(0.3 %)	(5.88)	17.9 %
2019	245.51	8.8 %	69.38	31.6 %	(6.30)	(7.2 %)
2020	255.32	4.0 %	67.87	(2.2 %)	1.73	127.4 %
2021	269.56	5.6 %	64.55	(4.9 %)	(10.12)	(685.4 %)
2022	266.23	(1.2 %)	16.83	(73.9 %)	(57.14)	(464.4 %)
2023	20.09	(92.5 %)	3.66	(78.2 %)	(8.63)	84.9 %
2024	15.44	(23.1 %)	2.45	(33.1 %)	(13.13)	(52.1 %)

Profitability

Period	Gross Margin	OIBDA Margin	Net Margin Before Unusual Items
Q1 2015	21.83 %	(65.06 %)	75.87 %
Q2 2015	26.33 %	(17.50 %)	69.87 %
Q3 2015	26.11 %	(6.83 %)	5.79 %
Q4 2015	26.09 %	4.77 %	8.07 %
2015	25.51 %	4.19 %	(0.75 %)
Q1 2016	25.88 %	5.37 %	4.76 %
Q2 2016	25.36 %	6.95 %	(14.75 %)
Q3 2016	26.45 %	8.29 %	(8.05 %)
Q4 2016	25.18 %	4.00 %	(8.51 %)
2016	25.16 %	3.98 %	(8.88 %)
Q1 2017	24.97 %	4.40 %	(7.26 %)
Q2 2017	25.44 %	4.43 %	(0.68 %)
Q3 2017	24.52 %	4.39 %	0.95 %
Q4 2017	25.30 %	3.92 %	(3.32 %)
2017	25.30 %	3.92 %	(3.32 %)
Q1 2018	24.94 %	2.88 %	(5.08 %)
Q2 2018	23.76 %	2.89 %	(5.72 %)
Q3 2018	23.59 %	3.08 %	(5.16 %)
Q4 2018	23.37 %	3.99 %	3.20 %
2018	23.37 %	3.99 %	3.20 %
Q1 2019	23.86 %	5.12 %	4.96 %
Q2 2019	24.57 %	2.19 %	5.56 %
Q3 2019	24.91 %	5.57 %	5.97 %
Q4 2019	28.26 %	3.64 %	(0.48 %)
2019	28.26 %	3.64 %	(0.52 %)
Q1 2020	28.17 %	3.44 %	(0.51 %)
Q2 2020	28.43 %	6.70 %	0.28 %
Q3 2020	29.08 %	4.58 %	1.76 %
Q4 2020	26.58 %	7.00 %	3.80 %
2020	26.58 %	7.00 %	3.80 %
Q1 2021	27.71 %	7.51 %	5.95 %
Q2 2021	28.10 %	6.01 %	4.53 %
Q3 2021	27.25 %	6.12 %	3.64 %
Q4 2021	23.95 %	2.69 %	1.59 %
2021	23.95 %	2.69 %	1.59 %
Q1 2022	22.83 %	2.60 %	3.79 %
Q2 2022	20.59 %	0.66 %	(0.75 %)
Q3 2022	19.39 %	(7.48 %)	(8.32 %)
Q4 2022	6.32 %	(13.36 %)	(16.82 %)
2022	6.32 %	(13.36 %)	(16.82 %)
Q1 2023	(5.46 %)	(28.01 %)	(40.35 %)
Q2 2023	(10.93 %)	(35.56 %)	(49.69 %)
Q3 2023	(20.95 %)	(34.81 %)	(84.25 %)
Q4 2023	(8.67 %)	(28.93 %)	(139.52 %)
2023	18.24 %	151.98 %	(1076.67 %)
Q1 2024	(8.18 %)	(23.55 %)	(121.34 %)
Q2 2024	(10.91 %)	(2.65 %)	(205.53 %)
Q3 2024	(10.81 %)	(4.85 %)	(188.06 %)
Q4 2024	(10.88 %)	-	(149.33 %)
2024	15.87 %	-	(1064.93 %)

Period	Gross Margin	OIBDA Margin	Net Margin Before Unusual Items
2015	25.51 %	4.19 %	(0.75 %)
2016	25.16 %	3.98 %	(8.88 %)
2017	25.30 %	3.92 %	(3.32 %)
2018	23.37 %	3.99 %	3.20 %
2019	28.26 %	3.64 %	(0.52 %)
2020	26.58 %	7.00 %	3.80 %
2021	23.95 %	2.69 %	1.59 %
2022	6.32 %	(13.36 %)	(16.82 %)
2023	18.24 %	151.98 %	(1076.67 %)
2024	15.87 %	-	(1064.93 %)

Period	Gross Margin	OIBDA Margin	Net Margin Before Unusual Items
Q1 2015	27.93 %	(1.82 %)	18.60 %
Q2 2015	27.65 %	(1.00 %)	55.61 %
Q3 2015	25.00 %	(0.10 %)	(36.08 %)
Q4 2015	25.22 %	15.68 %	(0.81 %)
Q1 2016	25.61 %	5.79 %	(2.66 %)
Q2 2016	25.57 %	5.41 %	(22.33 %)
Q3 2016	29.70 %	6.00 %	(6.37 %)
Q4 2016	20.04 %	(1.24 %)	(2.22 %)
Q1 2017	24.80 %	7.27 %	1.98 %
Q2 2017	27.16 %	5.44 %	2.86 %
Q3 2017	25.57 %	5.65 %	0.78 %
Q4 2017	23.58 %	(2.46 %)	(18.66 %)
Q1 2018	23.40 %	2.95 %	(5.26 %)
Q2 2018	22.60 %	5.59 %	0.60 %
Q3 2018	24.69 %	5.97 %	2.03 %
Q4 2018	22.78 %	1.62 %	13.86 %
Q1 2019	25.37 %	7.55 %	2.46 %
Q2 2019	25.56 %	(6.20 %)	3.38 %
Q3 2019	26.02 %	19.14 %	3.82 %
Q4 2019	34.93 %	(4.80 %)	(9.98 %)
Q1 2020	25.27 %	6.38 %	2.10 %
Q2 2020	26.76 %	7.75 %	6.45 %
Q3 2020	28.78 %	9.70 %	9.37 %
Q4 2020	25.45 %	4.12 %	(2.73 %)
Q1 2021	29.57 %	8.34 %	10.16 %
Q2 2021	28.40 %	1.89 %	0.87 %
Q3 2021	25.24 %	10.18 %	5.68 %
Q4 2021	10.68 %	(11.25 %)	(12.21 %)
Q1 2022	25.30 %	7.80 %	17.75 %
Q2 2022	19.67 %	(6.04 %)	(17.81 %)
Q3 2022	20.32 %	(22.46 %)	(24.58 %)
Q4 2022	(51.36 %)	(39.17 %)	(52.45 %)
Q1 2023	(17.19 %)	(45.26 %)	(67.42 %)
Q2 2023	(3.16 %)	(35.77 %)	(53.98 %)
Q3 2023	2.69 %	207.36 %	(1308.34 %)
Q4 2023	15.14 %	97.69 %	(1435.62 %)
Q1 2024	(13.66 %)	(30.25 %)	(55.75 %)
Q2 2024	11.37 %	346.28 %	(1251.03 %)
Q3 2024	10.40 %	200.36 %	(1067.47 %)
Q4 2024	27.92 %	-	(815.01 %)

Per Share Data (Riyal)

Compared With The

Period	Shares Outstanding (M)	EPS (Riyal)	Earnings Per Share before unusual items (Riyal)	Book Value (BV)
Q1 2015	53.69	(0.64)	0.22	9.28
Q2 2015	53.69	(0.02)	0.79	9.91
Q3 2015	53.69	0.36	0.11	9.67
Q4 2015	53.69	0.77	0.23	9.85
Q1 2016	53.69	0.63	0.17	9.59
Q2 2016	53.69	(0.16)	(0.53)	9.34
Q3 2016	53.69	(0.35)	(0.29)	9.24
Q4 2016	53.69	(0.61)	(0.30)	9.09
Q1 2017	53.69	(0.54)	(0.26)	9.08
Q2 2017	53.69	(0.27)	(0.03)	9.07
Q3 2017	53.69	(0.26)	0.04	9.09
Q4 2017	53.69	(0.18)	(0.13)	8.89
Q1 2018	53.69	(0.25)	(0.20)	9.66
Q2 2018	53.69	(0.27)	(0.22)	9.72
Q3 2018	53.69	(0.21)	(0.21)	9.73
Q4 2018	53.69	0.13	0.13	9.79
Q1 2019	53.69	0.21	0.21	9.76
Q2 2019	53.69	0.24	0.24	9.17
Q3 2019	53.69	0.26	0.26	9.33
Q4 2019	53.69	(0.02)	(0.02)	9.63
Q1 2020	80.79	0.16	(0.02)	9.28
Q2 2020	80.79	0.19	0.01	9.34
Q3 2020	80.79	0.27	0.06	9.45
Q4 2020	80.79	0.34	0.12	9.29
Q1 2021	82.68	0.23	0.19	9.38
Q2 2021	82.68	0.19	0.15	9.39
Q3 2021	82.68	0.12	0.12	9.44
Q4 2021	82.68	0.05	0.05	9.15
Q1 2022	88.35	0.12	0.12	9.30
Q2 2022	88.35	(0.02)	(0.02)	9.17
Q3 2022	88.35	(0.25)	(0.25)	8.98
Q4 2022	88.35	(0.51)	(0.51)	8.33
Q1 2023	88.35	(1.19)	(1.19)	7.80
Q2 2023	88.35	(1.52)	(1.52)	7.33
Q3 2023	88.35	(1.97)	(1.97)	6.69
Q4 2023	88.35	(2.45)	(2.45)	5.66
Q1 2024	88.35	(2.55)	(2.55)	5.01
Q2 2024	88.35	(2.63)	(2.63)	4.46
Q3 2024	92.72	(2.27)	(2.27)	5.50
Q4 2024	92.72	(1.77)	(1.77)	6.03

Period	Shares Outstanding (M)	EPS (Riyal)	Earnings Per Share before unusual items (Riyal)	Book Value (BV)
2015	53.69	0.97	(0.02)	9.85
2016	53.69	(0.62)	(0.32)	9.09
2017	53.69	(0.18)	(0.13)	8.89
2018	53.69	0.13	0.13	9.79
2019	53.69	(0.02)	(0.02)	9.63
2020	80.79	0.34	0.12	9.29
2021	82.68	0.05	0.05	9.15
2022	88.35	(0.51)	(0.51)	8.33
2023	88.35	(2.45)	(2.45)	5.66
2024	92.72	(1.77)	(1.77)	6.03

Multiple Ratios (End of Period Price)

Compared With The

Period	P/E	Adjusted P/E	Price/book
Q1 2015	NEG	More than 100	2.69
Q2 2015	NEG	35.77	2.85
Q3 2015	51.44	More than 100	1.90
Q4 2015	27.54	93.24	2.14
Q1 2016	35.24	More than 100	2.30
Q2 2016	NEG	NEG	2.17
Q3 2016	NEG	NEG	1.86
Q4 2016	NEG	NEG	2.19
Q1 2017	NEG	NEG	2.84
Q2 2017	NEG	NEG	2.26
Q3 2017	NEG	More than 100	2.33
Q4 2017	NEG	NEG	2.32
Q1 2018	NEG	NEG	1.99
Q2 2018	NEG	NEG	2.02
Q3 2018	NEG	NEG	1.77
Q4 2018	More than 100	More than 100	1.74
Q1 2019	83.75	83.75	1.83
Q2 2019	72.46	72.46	1.92
Q3 2019	67.72	67.72	1.92
Q4 2019	NEG	NEG	2.00
Q1 2020	65.93	NEG	1.17
Q2 2020	67.79	More than 100	1.37
Q3 2020	65.70	More than 100	1.91
Q4 2020	66.64	More than 100	2.42
Q1 2021	More than 100	More than 100	2.55
Q2 2021	More than 100	More than 100	3.39
Q3 2021	More than 100	More than 100	3.10
Q4 2021	More than 100	More than 100	2.31
Q1 2022	More than 100	More than 100	2.13
Q2 2022	NEG	NEG	1.91
Q3 2022	NEG	NEG	1.93
Q4 2022	NEG	NEG	1.76
Q1 2023	NEG	NEG	2.08
Q2 2023	NEG	NEG	2.78
Q3 2023	NEG	NEG	2.36
Q4 2023	NEG	NEG	2.87
Q1 2024	NEG	NEG	4.20
Q2 2024	NEG	NEG	4.12
Q3 2024	NEG	NEG	3.02
Q4 2024	NEG	NEG	2.51

Period	P/E	Adjusted P/E	Price/book
2015	21.76	NEG	2.14
2016	NEG	NEG	2.19
2017	NEG	NEG	2.32
2018	More than 100	More than 100	1.74
2019	NEG	NEG	2.00
2020	66.64	More than 100	2.42
2021	More than 100	More than 100	2.31
2022	NEG	NEG	1.76
2023	NEG	NEG	2.87
2024	NEG	NEG	2.51

Business Segments (Million)

Compared With The

Period	Manufacturing sector	medical service	Investments	Food
Q1 2015	2.59	6.92	-	-
Q2 2015	3.43	44.09	-	-
Q3 2015	1.75	41.55	-	-
Q4 2015	3.15	47.09	-	-
Q1 2016	3.10	46.51	-	-
Q2 2016	4.04	45.56	-	-
Q3 2016	1.51	43.72	-	-
Q4 2016	2.81	44.67	-	-
Q1 2017	2.67	47.97	-	-
Q2 2017	4.98	50.48	-	-
Q3 2017	2.91	46.87	-	-
Q4 2017	2.59	50.60	-	-
Q1 2018	2.78	50.24	-	-
Q2 2018	5.45	48.22	-	-
Q3 2018	2.73	54.82	-	-
Q4 2018	3.75	57.67	-	-
Q1 2019	3.91	53.71	-	-
Q2 2019	4.17	54.45	-	-
Q3 2019	3.62	56.65	-	-
Q4 2019	4.75	64.25	-	-
Q1 2020	4.85	58.48	-	-
Q2 2020	4.01	57.41	-	-
Q3 2020	3.74	62.20	-	-
Q4 2020	4.18	60.44	-	-
Q1 2021	4.95	67.58	-	-
Q2 2021	3.77	66.66	-	-
Q3 2021	3.57	62.23	-	-
Q4 2021	4.63	56.17	-	-
Q1 2022	5.59	70.01	-	-
Q2 2022	4.03	61.83	-	-
Q3 2022	4.22	63.91	-	-
Q4 2022	5.42	51.22	-	-
Q1 2023	6.52	62.67	-	-
Q2 2023	4.24	-	-	-
Q3 2023	4.31	-	-	-
Q4 2023	5.01	88.71	-	-
Q1 2024	5.17	94.66	-	-
Q2 2024	3.86	-	-	-
Q3 2024	3.25	-	-	-

Period	Manufacturing sector	medical service	Investments	Food
2014	6.79	-	-	-
2015	10.91	139.65	-	-
2016	11.47	180.46	-	-
2017	13.15	195.92	-	-
2018	14.71	210.95	-	-
2019	16.44	229.06	-	-
2020	16.78	238.53	-	-
2021	16.92	252.64	-	-
2022	19.26	246.97	-	-
2023	20.09	313.19	-	-

Financial Ratios

	Current
Market Cap (M Riyal)	1,712.89
Enterprise Value (EV) (M)	1,701.93
Shares Outstanding ((M))	100.64
EPS ( Riyal) (TTM)	(1.77)
Book Value (BV) ( Riyal)	6.03
Par Value ( Riyal)	10.00
Adjusted P/E (Last12)	Neg
P/E (TTM)	NEG
Price/book	2.82
Return on Average Assets (%) (TTM)	(9.94 )
Return on Average Equity (%) (TTM)	(14.47 )

AYYAN Investment Co. (AYYAN)

Twitter

Facebook

Linked in

Comments {{getCommentCount()}}

Be the first to comment

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

Sorry: the validity period has ended to comment on this news

Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

AYYAN loses SAR 164.4M in 2024, SAR 25.8M in Q4

View other reports

Financials (M)

Current Quarter Comparison (M)

Profit Performance (Million)

Profit Performance (Million)

Financial results (Million)

Financial results (Million)

Profitability

Profitability

Per Share Data (Riyal)

Per Share Data (Riyal)

Multiple Ratios (End of Period Price)

Ratios And Multiples

Business Segments (Million)

Revenue by Business Segment (Latest) 2024 Q4

Financial Ratios

Share Price

AYYAN Investment Co. (AYYAN)

Comments {{getCommentCount()}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}}

×

AYYAN loses SAR 164.4M in 2024, SAR 25.8M in Q4

Content Summary:

Comments Analysis:

View other reports

Financials (M)

Current Quarter Comparison (M)

Profit Performance (Million)

Profit Performance (Million)

Financial results (Million)

Financial results (Million)

Profitability

Profitability

Per Share Data (Riyal)

Per Share Data (Riyal)

Multiple Ratios (End of Period Price)

Ratios And Multiples

Business Segments (Million) Q3 2024

Revenue by Business Segment (Latest) 2024 Q4

Financial Ratios

Share Price

AYYAN Investment Co. (AYYAN)

Comments {{getCommentCount()}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}}

Business Segments (Million)